Literature DB >> 18561180

Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP project.

Paolo Indolfi1, Gianni Bisogno, Giovanni Cecchetto, Filippo Spreafico, Gian Luca De Salvo, Paola Collini, Alessandro Jenkner, Alessandro Inserra, Amalia Schiavetti, Martina di Martino, Fiorina Casale.   

Abstract

BACKGROUND: One of the most important adverse prognostic factors for adult renal cell carcinoma (RCC) is the retroperitoneal lymph node involvement. The aim of this article is to study the prognostic significance of local lymph node involvement in pediatric RCC and the role of retroperitoneal lymph node dissection (RLND) at diagnosis. PROCEDURE: The series included 16 patients with RCC and lymph nodes involvement registered in the Italian Rare Tumors Pediatric Age (TREP) project, accounting for 26.2% of 61 pediatric RCC observed at AIEOP centers.
RESULTS: A radical nephrectomy was performed in all cases: at diagnosis in 12 cases, after preoperative chemotherapy (CT) in 4 cases. As a part of the same procedure 9 patients underwent RLND, and 7 received a more limited lymph nodes resection. Five (31.2%) developed disease recurrence 2-34 months after diagnosis (median, 6 months) plus 1 developed progression; 6 patients died, 1 of them from secondary leukemia. Among the nine patients receiving RLND, eight are alive and disease free. This compares with only one patient surviving among the seven receiving a more limited lymph nodes resection. The estimated 25-year PFS and OS rates for all patients were 61.4% (95% CI 33.2-80.5) and 50.8% (95% CI 16.5-77.5), respectively.
CONCLUSIONS: Lymph node involvement is an unfavorable prognostic factor in children with RCC. RLND appears to be a critical factor to improve the outcome. However, when compared to similar adult patients, the outcome in children appears to be better, suggesting that pediatric RCC, or the host, may be critical differences. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18561180     DOI: 10.1002/pbc.21652

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

1.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

Authors:  James I Geller; Peter F Ehrlich; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Eric J Gratias; Arlene Naranjo; Jeffrey S Dome; Elizabeth J Perlman
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

2.  Reliability of intraoperative frozen section for the diagnosis of renal tumors suspicious for malignancy in children and adolescents.

Authors:  Alonso Carrasco; Brian T Caldwell; Carrye R Cost; Brian S Greffe; Timothy P Garrington; Jennifer L Bruny; Jennifer O Black; Nicholas G Cost
Journal:  Pediatr Blood Cancer       Date:  2017-01-18       Impact factor: 3.167

3.  Factors impacting survival in children with renal cell carcinoma.

Authors:  Kristy L Rialon; Brian C Gulack; Brian R Englum; Jonathan C Routh; Henry E Rice
Journal:  J Pediatr Surg       Date:  2015-03-14       Impact factor: 2.545

4.  A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.

Authors:  James I Geller; Nicholas G Cost; Yueh-Yun Chi; Brett Tornwall; Mariana Cajaiba; Elizabeth J Perlman; Yeonil Kim; Elizabeth A Mullen; Richard D Glick; Geetika Khanna; Najat C Daw; Peter Ehrlich; Conrad V Fernandez; Jeffrey S Dome
Journal:  Cancer       Date:  2020-09-14       Impact factor: 6.860

5.  Pediatric Clear Cell Renal Cell Carcinoma with Pelvicalyceal System Invasion and Contiguous Extension Upto Bladder: Novel and Bizarre Tumor Behaviour.

Authors:  Narvir S Chauhan; Ramesh Bharti; Bal Chander; Satish Kumar
Journal:  Pol J Radiol       Date:  2016-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.